CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
Magnesium Sulfate +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01113138
NCT01113138N/ACompleted
CompareCT.gov

Pharmacokinetic Study of Mablet as Oral Supplement and Magnesium Sulfate as Infusion

University of Aarhus·interventional·Posted Apr 29, 2010·Updated Jan 13, 2014

In Brief

A clinical study evaluating Mablet (Magnesium-supplement) and Magnesium Sulfate for Asthma and Chronic Obstructive Pulmonary Disease. Completed, enrolled 10 participants across 1 site.

Detailed Summary

The present study is part of a project titled 'Magnesium in asthma and chronic obstructive pulmonary disease'. The hypothesis of the main project is that daily magnesium supplement will benefit patients with asthma and chronic obstructive pulmonary disease. The aim of this part of the project is to study the pharmacokinetics of the following two magnesium supplements: * Mablet (dietary supplement) * Magnesium Sulfate (solution for infusion)

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma, Chronic Obstructive Pulmonary Disease
CountriesDenmark
CollaboratorsGunnar Kjems APS, GCP-unit at Aarhus University Hospital, Aarhus, Denmark, Aarhus University Hospital

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 29, 2010
Enrollment StartDec 1, 2012
Primary CompletionJan 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 16.2 years ago

Interventions

Mablet (Magnesium-supplement)dietary

Mablet: Magnesium hydroxide/ -oxide (360 mg/tablet) 3 tablets as a single dose Produced by: Gunnar Kjems APS

Magnesium Sulfatedrug

Solution for a single bolus-infusion, containing 2 grams of magnesium sulfate.